Related Experiment Video
Updated: Jul 11, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Vaccination updates and special considerations for systemic lupus erythematosus patients
Jammie Law1, Cristina Sorrento, Amit Saxena
1Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Purpose Of Review:
We review the latest guidelines and note special considerations for systemic lupus erythematosus (SLE) patients when approaching vaccination against SARS-CoV-2, influenza, pneumococcus, herpes zoster, and potentially respiratory syncytial virus (RSV) vaccine in the future.
Recent Findings:
SLE patients have unique infectious risks due to newer treatments and the nature of the disease itself. It is important to balance the benefit of additional protective immunity from updated vaccines against the possible risk of disease activity exacerbations.
Summary:
It is important to continuously evaluate the safety and immunogenicity of updated vaccines specifically for SLE patients. Additionally, the newly approved RSV vaccine should be considered for this population to reduce severe respiratory illness.
Related Concept Videos
Vaccinations
Myocarditis IV: Nursing Management
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Rheumatic Heart Disease IV: Nursing Management
Myocarditis III: Medical Management
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

